These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of severe asthma with anti-immunoglobulin E (Omalizumab). A new possibility in pulmonary medicine].
    Author: Nolte H, Harving H, Backer V.
    Journal: Ugeskr Laeger; 2007 Dec 10; 169(50):4366-7. PubMed ID: 18211797.
    Abstract:
    Xolair has recently been approved for the treatment of patients with inadequately controlled severe asthma. Three unstable atopic asthmatics, treated with high doses of inhaled steroid, nasal steoids, Montelukast or systemic corticosteroids, were offered injections with Xolair. Median IgE values were 200 kU/L. All three patients tolerated the treatment well with considerable clinical improvement (during 6 months). In this clinical setting, treatment with Xolair was successfully carried out in a respiratory out-patient clinic.
    [Abstract] [Full Text] [Related] [New Search]